Clin2
NCT07383142Possibly a fitNot yet recruiting

Chemotherapy in the chest for thymoma with pleural spread

Thymic Epithelial Tumor

Part of Cancer clinical trials.

This trial tests giving chemotherapy directly into the chest cavity during surgery for thymoma that has spread to the lining of the lung (pleura) or has come back there. The goal is to see if this approach can help control the disease and improve outcomes.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
202 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old and expected to live more than a year.
  • You have a type of thymoma (TET) that has spread to the pleura, either when first found or as a return after previous surgery.
  • The pleural tumor spots can be removed during surgery, and a biopsy during surgery confirms they are thymoma.
  • You do not have cancer spread to other parts of the body like the heart sac, lungs, or distant organs.
  • You have not had more than one prior surgery for the same condition, and any prior radiotherapy was less than 60 Gy.
  • You do not have unstable myasthenia gravis, serious heart disease, or active infections.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07328074Not yet recruiting
Surgery and heated chemotherapy for thymus cancer spread

This trial tests combining surgery with heated chemotherapy delivered directly into the chest cavity for people whose thymus cancer has spread to the lining of the lung. The goal is to see if this approach is safe and effective.

Shanghai, Shanghai Municipality
NCT05667948Recruiting
Testing targeted treatments for thymus cancer using tumor testing

This trial studies people with thymus (thymic) cancers that have been confirmed by tissue testing. It uses tumor “molecular” (biologic/genetic) test results to guide treatment options and see how well they work.

Shanghai, Shanghai Municipality
NCT05104736Recruiting· Phase 2
PT-112 for thymus gland tumors after prior chemotherapy

This trial studies PT-112, a new treatment, in people with thymoma or thymic carcinoma that has grown despite at least one prior platinum chemotherapy treatment. It may help shrink tumors or slow disease progression, especially when surgery is not possible.

Bethesda, Maryland
NCT06402708Recruiting· Phase 3
Chemotherapy after surgery for thymic cancer

This trial tests whether additional chemotherapy after surgery can help prevent thymic cancer from coming back. It is for people who have had their thymus tumor completely removed and are in good health.

Shanghai, Shanghai Municipality
NCT06924619Recruiting· Phase 2
Radiation before surgery for advanced thymoma

This trial tests giving radiation therapy before surgery for a type of thymus gland tumor (thymoma) that has grown into nearby tissues but has not been treated yet. The goal is to see if this approach can make the tumor removable and improve outcomes.

Hangzhou, Zhejiang
NCT07463313Not yet recruiting· Phase 2/Phase 3
6 vs 3 cycles of chemo before surgery for advanced thymus cancer

This trial tests whether 6 cycles of chemotherapy before surgery works better than 3 cycles for people with advanced thymus gland tumors that can be surgically removed. It aims to improve treatment outcomes for locally advanced thymoma or thymic carcinoma.

Shanghai, Shanghai Municipality

Hear when a new Thymic Epithelial Tumor trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.